Sign in

CIK 0000906709

  • Non-accelerated filer
  • Smaller reporting company

NEKTAR THERAPEUTICS

Sign in to watch
Ticker
NKTR
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
943134940
Phone
+1 415-482-5300
Business address
455 MISSION BAY BOULEVARD SOUTH, SAN FRANCISCO, CA, 94158
Former names
INHALE THERAPEUTIC SYSTEMS INC, INHALE THERAPEUTIC SYSTEMS
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-09-23 WHITFIELD ROY A Director Grant or award +2,000 16,417
2026-09-23 WHITFIELD ROY A Director Grant or award · Stock Option +4,000 4,000
2026-09-23 GREER R SCOTT Director Grant or award +2,000 22,239
2026-09-23 GREER R SCOTT Director Grant or award · Stock Option +4,000 4,000
2026-09-23 CHESS ROBERT Director Grant or award +2,000 19,019
2026-09-23 CHESS ROBERT Director Grant or award · Stock Option +4,000 4,000
2026-09-23 Brainard Diana Director Grant or award +2,000 3,904
2026-09-23 Brainard Diana Director Grant or award · Stock Option +4,000 4,000
2026-09-23 Ajer Jeffrey Robert Director Grant or award +2,000 4,277
2026-09-23 Ajer Jeffrey Robert Director Grant or award · Stock Option +4,000 4,000
2026-08-18 Zalevsky Jonathan Chief R&D Officer Sale −186 $71.98 $13K 9,570
2026-08-18 ROBIN HOWARD W President & CEO Sale −418 $71.98 $30K 54,627
2026-07-24 Zalevsky Jonathan Chief R&D Officer Grant or award · Stock Option +16,500 16,500
2026-07-24 ROBIN HOWARD W President & CEO Grant or award · Stock Option +57,200 57,200
2026-06-30 Zalevsky Jonathan Chief R&D Officer Sale 10b5-1 −5,681 $70.00 $398K 9,756
2026-06-17 ROBIN HOWARD W President & CEO Sale 10b5-1 −5,500 $60.81 $334K 59,545
2026-06-17 ROBIN HOWARD W President & CEO Sale 10b5-1 −4,500 $61.65 $277K 55,045
2026-06-16 ROBIN HOWARD W President & CEO Sale 10b5-1 −5,303 $59.97 $318K 69,742
2026-06-16 ROBIN HOWARD W President & CEO Sale 10b5-1 −4,697 $60.71 $285K 65,045
2026-06-15 Zalevsky Jonathan Chief R&D Officer Sale 10b5-1 −5,538 $60.71 $336K 15,437

Page 1 of 55 · 1,088 trades